Gene editing nanocapsule, and preparation method and application thereof
A nanocapsule and gene editing technology, applied in the field of gene editing, can solve the problems of poor cell membrane permeability and low stability, achieve good biocompatibility and biosafety, small particle size, and high cell endocytosis efficiency Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0108] Embodiment 1 ANC SS Preparation method of (Cas9 / sgRNA) nanocapsules
[0109] Step 1, Cas9 and sgRNA were added to 500 μl 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES buffer) (10mM PH7.4) at a molar ratio of 1:1.2, and incubated at room temperature 5 minutes.
[0110] Specifically, the target gene of the sgRNA is the PLK1 gene, and the sequence of the target site of the sgRNA on the PLK1 gene is shown in SEQ ID NO:1.
[0111] Step 2. Transfer the above system to a 4°C environment, add acrylate polyethylene glycol succinyl carboxymethyl ester and stir for 10 minutes, then add guanidine acrylate and stir for 5 minutes, then add degradable N,N'-bis (acryloyl)cystamine, wherein the molar ratio of acrylate polyethylene glycol succinylcarboxymethyl ester, guanidinoacrylate, and N,N'-bis(acryloyl)cystamine is 1:1:1. Add 3 mg of ammonium persulfate and 3 μL of N, N, N', N'-tetramethylethylenediamine solution to initiate the polymerization reaction immediately. Th...
Embodiment 2
[0117] Embodiment 2 ANC SS Preparation method of (Cas9 / sgRNA) nanocapsules
[0118] The only difference from the above-mentioned Example 1 is that the molar ratio of the Cas nuclease to the guanidinoacrylate is 1:200.
Embodiment 3
[0119] Embodiment 3 ANC SS Preparation method of (Cas9 / sgRNA) nanocapsules
[0120] The only difference from the above-mentioned Example 1 is that the molar ratio of the Cas nuclease to the guanidinoacrylate is 1:250.
PUM
| Property | Measurement | Unit |
|---|---|---|
| particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


